$HCA Healthcare (HCA.US)$ 🎯 April 10, 2024, current price i...

New data: Q3 2023, Q4 2023, continuous revenue growth, operating profit contracted in Q3 due to expense growth, recovered in Q4, net income continuously shrank due to interest expenses.

Revenue in 2023 increased by 7.9%, operating profit increased by 6.3%, essentially returning to the level of 2021, net income shrank by 10.9% due to lack of business sale gains. In fact, the net income in 2021 and 2022 was inflated due to business sales. The average net income growth rate over the past 3 years is 11.6%.

The asset-liability ratio has decreased from 100.1% to 98.1%, and the net asset has finally turned positive, with a slight increase in cash and accounts receivable amounting to 9.96 billion, which is still at a normal ratio. Short-term borrowings on the liability side have increased significantly.

Operating cash flow exceeds investment cash flow, resulting in certain shareholder surplus.

Currently, the pe is 17.3, and the valuation is still within a reasonable range, so no adjustments are being made at the moment.